Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone program help cancer patients decide about fertility?

NCT ID NCT07701252

Knowledge-focused Sponsor: Benha University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests a digital education program designed to help newly diagnosed women with gynecological cancer learn about egg freezing (oocyte cryopreservation). The program uses videos, images, WhatsApp, and online meetings to teach about fertility preservation options. Researchers measure changes in knowledge, attitudes, and decision-making confidence before and after the program.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Digital health literacy education intervention
What this could lead to
If successful, this approach could help women with gynecological cancer make more informed decisions about fertility preservation before starting cancer treatment.
What could go wrong
This is a small, single-group study without a comparison group, so improvements may not be due to the intervention alone. Results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

158 people

The number who actually took part.

Started

Sep 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Newly diagnosed women with gynecological cancers who had not received any treatment. * Women of reproductive age, 18-45 years. * Women with gynecological cancers who had not received cryopreservation instructions before. * Women who had a smartphone, internet connection, could use social media, and had access to the internet through their phone. Exclusion Criteria: * Women with gynecological cancer who had received cancer treatment, including chemotherapy, radiotherapy, or hormonal therapy. * Women diagnosed with learning difficulties, such as dementia or vision impairment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Digital health literacy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior female reproductive organ cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Digital health literacy Fertility preservation Gynecological cancer Oocyte cryopreservation

Contacts and locations

Locations

  • Oncology Center, Mansoura University Hospital

    Al Mansurah, Dakahlia Governorate, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.